Korbinian Arthur Maria Löbmann
Directeur/Bestuurslid bij Zerion Pharma ApS
Oorsprong van het eerstegraads netwerk van Korbinian Arthur Maria Löbmann
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Zerion Pharma ApS
Zerion Pharma ApS Pharmaceuticals: MajorHealth Technology Zerion ApS operates as pharmaceutical development company. It also develops and improve drug products. The company was founded on January 14, 2019 and is headquartered in Birkerod, Denmark.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Korbinian Arthur Maria Löbmann via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Heriot-Watt University | College/University | Masters Business Admin | |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Chief Executive Officer | |
BI Norwegian Business School | College/University | Undergraduate Degree | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Medical/Nursing Services | Chief Executive Officer | |
Vectron Biosolutions AS
Vectron Biosolutions AS BiotechnologyHealth Technology Vectron Biosolutions AS is a Norwegian company that specializes in developing protein production processes for researchers and manufacturers. The company is based in Trondheim, NO. The company's mission is to support their customers in realizing higher success rates, greater yields, and reduced cost of goods. The company offers tailor-made solutions by leveraging their proprietary expression technologies and extensive experience. and has subsidiaries in the United States. The company was founded in 2008, and Trond Erik Vee Aune has been the CEO of the company since 2008. | Biotechnology | Chairman |
Statistieken
Internationaal
Noorwegen | 4 |
Verenigd Koninkrijk | 2 |
Verenigde Staten | 2 |
Denemarken | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 6 |
Chief Executive Officer | 3 |
Chairman | 3 |
President | 2 |
Masters Business Admin | 1 |
Sterkste connecties
- Beurs
- Insiders
- Korbinian Arthur Maria Löbmann
- Bedrijfsconnecties